Anti‐platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation

Greinacher, 1991, A rapid and sensitive test for diagnosing heparin‐associated thrombocytopenia, Thromb Haemost, 66, 734, 10.1055/s-0038-1646493 Amiral, 1992, Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin‐induced thrombocytopenia, Thromb Haemost, 68, 95, 10.1055/s-0038-1656329 Visentin, 1994, Antibodies from patients with heparin‐induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells, J Clin Invest, 93, 81, 10.1172/JCI116987 Chong, 1989, Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with platelets, Br J Haematol, 73, 235, 10.1111/j.1365-2141.1989.tb00258.x Warkentin, 1994, Sera from patients with heparin‐induced thrombocytopenia generate platelet‐derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin‐induced thrombocytopenia, Blood, 84, 3691, 10.1182/blood.V84.11.3691.bloodjournal84113691 Tardy‐Poncet, 2009, Thrombin generation and heparin‐induced thrombocytopenia, J Thromb Haemost, 7, 1474, 10.1111/j.1538-7836.2009.03514.x Hughes, 2000, Morphological analysis of microparticle generation in heparin‐induced thrombocytopenia, Blood, 96, 188, 10.1182/blood.V96.1.188 Chilver‐Stainer, 2004, Titre of anti‐heparin/PF4‐antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems, Thromb Haemost, 91, 276, 10.1160/TH03-07-0454 Warkentin, 2011, HIT paradigms and paradoxes, J Thromb Haemost, 9, 105, 10.1111/j.1538-7836.2011.04322.x Warkentin, 2004, Heparin‐induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 311S, 10.1378/chest.126.3_suppl.311S Greinacher, 2009, The temporal profile of the anti‐PF4/heparin immune response, Blood, 113, 4970, 10.1182/blood-2008-08-173062 Greinacher, 2009, Heparin‐induced thrombocytopenia, J Thromb Haemost, 7, 9, 10.1111/j.1538-7836.2009.03385.x Warkentin, 2009, Studies of the immune response in heparin‐induced thrombocytopenia, Blood, 113, 4963, 10.1182/blood-2008-10-186064 Suvarna, 2005, PF4/heparin complexes are T cell‐dependent antigens, Blood, 106, 929, 10.1182/blood-2004-12-4955 Zheng, 2013, Critical role for mouse marginal zone B cells in PF4/heparin antibody production, Blood, 121, 3484, 10.1182/blood-2013-01-477091 Zarrinpar, 2012, Immunomodulating options for liver transplant patients, Expert Rev Clin Immunol, 8, 565, 10.1586/eci.12.47 Belghiti, 1992, A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion, Surg Gynecol Obstet, 175, 270 Dickson, 1999, The utility of noninvasive serologic markers in the management of early allograft rejection in liver transplantation recipients, Transplantation, 68, 247, 10.1097/00007890-199907270-00015 Jochum, 2011, Glutathione‐S‐transferase subtypes alpha and pi as a tool to predict and monitor graft failure or regeneration in a pilot study of living donor liver transplantation, Eur J Med Res, 16, 34, 10.1186/2047-783X-16-1-34 Cuker, 2010, The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion, J Thromb Haemost, 8, 2642, 10.1111/j.1538-7836.2010.04059.x Lo, 2006, Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings, J Thromb Haemost, 4, 759, 10.1111/j.1538-7836.2006.01787.x Messmore, 2011, Simple scoring system for early management of heparin‐induced thrombocytopenia, Clin Appl Thromb Hemost, 17, 197, 10.1177/1076029610387126 Juhl, 2006, Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia, Eur J Haematol, 76, 420, 10.1111/j.1600-0609.2005.00621.x Warkentin, 2011, How I diagnose and manage HIT, Hematology Am Soc Hematol Educ Program, 2011, 143, 10.1182/asheducation-2011.1.143 Dummer, 2012, FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance, Transpl Immunol, 26, 1, 10.1016/j.trim.2011.08.009 Kim, 2013, The imbalance of T helper 17/regulatory T cells and memory B cells during the early post‐transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor‐based immunosuppression, Immunology, 138, 124, 10.1111/imm.12021 Demirkiran, 2006, Low circulating regulatory T‐cell levels after acute rejection in liver transplantation, Liver Transpl, 12, 277, 10.1002/lt.20612 Verdonk, 2007, Effects of different immunosuppressive regimens on regulatory T‐cells in noninflamed colon of liver transplant recipients, Inflamm Bowel Dis, 13, 703, 10.1002/ibd.20087 Verdonk, 2007, Liver transplantation: an update, Neth J Med, 65, 372 Fagarasan, 2000, T‐Independent immune response: new aspects of B cell biology, Science, 290, 89, 10.1126/science.290.5489.89 Maruyama, 2007, Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome, Hepatogastroenterology, 54, 493 Huser, 2012, Heparin‐induced thrombocytopenia (HIT II) in liver transplant recipients: a retrospective multivariate analysis of prognostic factors, Transpl Int, 25, 739, 10.1111/j.1432-2277.2012.01486.x Kaneko, 2008, Heparin‐induced thrombocytopenia after liver transplantation, Transplant Proc, 40, 1518, 10.1016/j.transproceed.2008.01.069 Fretschner, 2005, Management of liver transplantation in a patient with a history of heparin‐induced thrombocytopenia, Transpl Int, 18, 664, 10.1111/j.1432-2277.2005.00111.x Bachmann, 2011, Donor heparinization is not a contraindication to liver transplantation even in recipients with acute heparin‐induced thrombocytopenia type II: a case report and review of the literature, Transpl Int, 24, e89, 10.1111/j.1432-2277.2011.01323.x Warkentin, 2013, Anti‐PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis, J Thromb Haemost, 11, 253, 10.1111/jth.12098 Panasiuk, 2001, Activation of blood platelets in chronic hepatitis and liver cirrhosis P‐selectin expression on blood platelets and secretory activity of beta‐thromboglobulin and platelet factor‐4, Hepatogastroenterology, 48, 818 Dominguez, 2009, Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis, Gastroenterology, 136, 1639, 10.1053/j.gastro.2009.01.056 Shi, 2013, Platelet factor 4 mediates vascular smooth muscle cell injury responses, Blood, 121, 4417, 10.1182/blood-2012-09-454710 Sachais, 2004, Interactions of platelet factor 4 with the vessel wall, Semin Thromb Hemost, 30, 351, 10.1055/s-2004-831048 Rauova, 2010, Monocyte‐bound PF4 in the pathogenesis of heparin‐induced thrombocytopenia, Blood, 116, 5021, 10.1182/blood-2010-03-276964 Kowalska, 2011, Antibodies associated with heparin‐induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT, Blood, 118, 2882, 10.1182/blood-2011-02-335208